http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105456201-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate | 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105456201-B |
| titleOfInvention | The preparation method of ambroxol albuterol pellets |
| abstract | The invention relates to ambroxoxalbutamol pellets and belongs to the field of pharmaceutical preparations. The poloxamer 188, meglumine and mannitol added to the pellets of the present invention in an appropriate amount can significantly improve the stability and bioavailability of ambroxol hydrochloride and salbutamol sulfate in the preparation, with stable quality and remarkable effect. Treatment of respiratory diseases such as acute and chronic bronchitis and asthma. |
| priorityDate | 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.